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Abstract 
The normal cellular prion protein, designated PrPC, is a membrane glycoprotein 
expressed most abundantly in brains, particularly by neurons, and to a lesser extent in 
non-neuronal tissues including lungs. Conformational conversion of PrPC into the 
amyloidogenic isoform is a key pathogenic event in prion diseases. We recently found 
that PrPC has a protective role against infection with influenza A viruses (IAVs) in mice 
by reducing reactive oxygen species in the lungs after infection with IAVs. The 
anti-oxidative activity of PrPC is probably attributable to its function to activate 
anti-oxidative enzyme Cu/Zn-superoxide dismutase, or SOD1, through regulating Cu 
content in lungs infected with IAVs. Oxidative stress could play a pivotal role in the 
pathogenesis of a wide range of viral infections. Here, we introduce our and others’ 
studies on the role of PrPC in viral infections, and raise the attractive possibility that 
PrPC might be a novel target molecule for development of anti-oxidative therapeutics 
against not only IAV infection but also other viral infections. 
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Introduction 
Viral infection frequently causes oxidative stress by inducing overproduction of reactive 
species such as reactive oxygen species (ROS) through enzymatic and non-enzymatic 
mechanisms in host cells (Camini et al., 2017; Li et al., 2017; Peterhans, 1997a; Schwarz, 
1996). ROS are chemically reactive molecules containing oxygen, including superoxide, 
hydrogen peroxide, and hydroxyl radical. The overproduced ROS overly oxidizes proteins, 
lipids, and DNA, thereby damaging these molecules in host cells eventually contributing to 
the pathogenesis of virus infection. Cells are also equipped with anti-oxidative mechanisms to 
balance cellular redox homeostasis. Superoxide dismutase (SOD), catalase, and glutathione 
peroxidase are major anti-oxidative enzymes (Sgarbanti et al., 2014). Another reactive species, 
nitric oxide (NO), also contributes to the pathogenesis of virus infections (Perrone et al., 
2013; Peterhans, 1997b). NO is produced by NO synthases (NOSs) and converted into the 
potent oxidative agent nitroperoxide through interaction with oxygen radicals, particularly 
superoxide (Akaike and Maeda, 2000). Mitigation of oxidative stress in host cells through 
either interfering with the oxidative mechanisms or enhancing the anti-oxidative mechanisms, 
or both, can be therapeutically beneficial for viral infections.  
The normal cellular prion protein, designated PrPC, is a membrane glycoprotein 
tethered to the outer cell membrane via a glycosylphosphatidylinositol anchor moiety and 
expressed most abundantly in brains, particularly by neurons, and to a lesser extent in 
non-neuronal tissues including hearts, kidneys, and lungs (Oesch et al., 1985; Prusiner, 1998). 
Conformational conversion of PrPC into the amyloidogenic isoform is a key pathogenic event 
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in prion diseases, a group of neurodegenerative disorders, which include Creutzfeldt-Jakob 
disease in humans and scrapie and bovine spongiform encephalopathy in animals (Prusiner, 
1998). Several lines of evidence have suggested that PrPC might have an anti-oxidative 
function. PrPC binds to copper (Cu) ions via the histidine residues within the N-terminally 
located octapeptide repeat (OR) region, which is comprised of 5 tandem repeats of 8 amino 
acids (Jackson et al., 2001). PrPC is suggested to regulate anti-oxidative enzymes, such as 
Cu/Zn-SOD, or SOD1, via transfer of the bound Cu ions to the enzymes (Haigh and Brown, 
2006). Other cellular functions, including cell trafficking, cell adhesion, cell differentiation, 
cell signaling, and cell survival, have been also suggested for PrPC (Aguzzi et al., 2008).  
We recently found that PrPC has a protective role against infection with influenza A 
viruses (IAVs) in mice probably through its anti-oxidative function (Chida et al., 2018). 
There have been also several reports that PrPC might be involved in protection against 
different virus infections through different mechanisms (Alais et al., 2012; Baj et al., 2005; 
Caruso et al., 2009; Nakamura et al., 2003; Nasu-Nishimura et al., 2008; Thackray and 
Bujdoso, 2002). Here, we introduce our and others’ studies on the role of PrPC in virus 
infections. 
 
Anti-oxidative treatments against IAV infection in mice 
IAV is an enveloped, negative sense, single-stranded RNA virus, causing seasonal epidemics 
of influenza (Fiore et al., 2008). High morbidity and mortality are observed in infected people, 
particularly in the young and elderly and those with underlying chronic diseases in lung or 
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cardiovascular systems (Fiore et al., 2008). Several lines of evidence indicate that ROS plays 
a pivotal role in the pathogenesis of IAV infection (Akaike et al., 1990; Oda et al., 1989; 
Tantcheva et al., 2003; Vlahos and Selemidis, 2014). Mice deficient in NOX2, a subunit of 
the ROS-producing multi-protein complex enzyme nicotinamide adenine dinucleotide 
phosphate (NADPH) oxidase, showed reduced lung injuries after infection with IAV/X-31 
(H3N2) and IAV/Puerto Rico/8/34 (H1N1) (hereafter referred to as IAV/PR8) (Vlahos et al., 
2011). The inhibitor of another ROS-producing enzyme xanthine oxidase (XO), allopurinol, 
also reduced mortality of mice infected with IAV/Kumamoto/Y5/67(H2N2) (referred to as 
IAV/Kumamoto) (Akaike et al., 1990). These results suggest that NADPH oxidase and XO 
are major ROS-producing enzymes in lungs infected with IAVs, and that reducing the 
oxidative mechanism could be effective in treatment for IAV infection. On the contrary, it 
was shown that administration of pyran polymer-conjugated SOD1 successfully reduced the 
mortality of mice infected with IAV/Kumamoto (Oda et al., 1989). It is thus suggested that 
SOD1 might be a major anti-oxidative enzyme in IAV infection and that enhancing the 
anti-oxidative mechanisms could be also therapeutically effective against IAV infection. 
Treatment with the NOS inhibitor, Nω-monomethyl-L-arginine, successfully reduced the 
mortality of mice infected with IAV/Kumamoto (Akaike et al., 1996), suggesting that NO 
could also play an important role in the pathogenesis of IAV infection. 
 
Anti-oxidative role of PrPC in protection against IAV infection  
SAKAGUCHI AND CHIDA 
 6 
We showed that PrPC was expressed by alveolar type 1 and 2 epithelial cells (AT1 and AT2 
cells) and bronchiolar Clara epithelial cells in mouse lungs (Chida et al., 2018), and that mice 
devoid of PrPC (Prnp0/0) were highly susceptible to intranasal infection with IAV/PR8, 
A/Aichi/2/68 (H3N2), and A/WSN/33 (H1N1), with markedly elevated mortality, compared 
to control wild-type (WT) mice (Chida et al., 2018). Infected Prnp0/0 lungs were severely 
damaged, with higher infiltration of inflammatory cells, higher levels of inflammatory 
cytokines and slightly but significantly higher virus titers than control WT lungs (Chida et al., 
2018). AT2 and Clara cells succumbed to apoptosis in infected Prnp0/0 lungs more than in 
control WT lungs (Chida et al., 2018). In contrast, AT1 cells were not damaged in infected 
Prnp0/0 and WT lungs (Chida et al., 2018). This is consistent with IAV/PR8 infection not 
damaging AT1 cells in C57BL/6 mice (Yamada et al., 2012). These results indicate that PrPC 
could have a protective role against lethal infection with IAVs in mice by mitigating lung 
injuries induced by IAV infection (Fig. 1). 
ROS levels were higher in IAV-infected Prnp0/0 lungs compared to control WT 
lungs (Chida et al., 2018). In addition, treatment with butylated hydroxyanisole, a ROS 
scavenger, decreased the mortality of infected Prnp0/0 mice to that of control WT mice (Chida 
et al., 2018). These results suggest that PrPC could play an anti-oxidative role to reduce ROS 
levels in IAV-infected lungs, thereby providing a protection against lethal infection with 
IAVs (Fig. 1). In contrast to higher ROS levels in infected Prnp0/0 lungs, Cu content and 
SOD1 activity were lower in infected Prnp0/0 lungs than in control WT mice (Chida et al., 
2018). It is thus conceivable that PrPC might exert its anti-oxidative role through regulation of 
SAKAGUCHI AND CHIDA 
 7 
the Cu content and SOD1 activity in IAV-infected lungs (Fig. 1). Tg(PrP∆OR)/Prnp0/0 mice, 
which express transgenic mouse PrP with a deletion of the Cu-binding OR region on the 
Prnp0/0 background (Yoshikawa et al., 2008), also showed lower Cu content, lower SOD1 
activity, and higher ROS levels in their lungs and higher mortality after infection with 
IAV/PR8 (Chida et al., 2018). These results suggest that the Cu-binding OR region plays an 
important role for PrPC to regulate the Cu content and SOD1 activity and then to exert the 
anti-oxidative effect in IAV-infected lungs (Fig. 1).  
IAVs primarily infect lung epithelial cells, including AT2 and Clara cells, and then 
cause oxidative stress in them (Liu et al., 2017; Sgarbanti et al., 2014; Short et al., 2014). 
Prnp0/0 epithelial cells do not sufficiently combat the oxidative stress due to lack of PrPC, 
therefore undergoing apoptosis more easily than WT epithelial cells after IAV infection. The 
higher apoptosis of Prnp0/0 epithelial cells then provokes higher inflammatory responses 
leading to higher production of inflammatory cytokines in infected Prnp0/0 lungs, eventually 
causing higher mortality of Prnp0/0 mice after infection with IAVs.  
 
Roles of PrPC in other virus infections 
Other groups have also investigated the roles of PrPC in other virus infections (Alais et al., 
2012; Baj et al., 2005; Caruso et al., 2009; Nakamura et al., 2003; Nasu-Nishimura et al., 
2008; Thackray and Bujdoso, 2002). Higher neuronal apoptosis was reported in the brains of 
Prnp0/0 mice than in control WT mice after infection with encephalomyocarditis virus B 
variant (EMCV-B), with less infiltration of inflammatory cells including microglia in infected 
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Prnp0/0 brains than in control WT brains (Nasu-Nishimura et al., 2008). EMCV-B was 
similarly replicated in the brains of infected Prnp0/0 and WT mice (Nasu-Nishimura et al., 
2008). These results suggest that PrPC might be involved in protection of neurons from 
EMCV-B infection-induced apoptosis possibly through activation of brain inflammatory 
responses against EMCV-B infection without affecting EMCV-B replication. It was also 
reported that PrPC might be involved in protection against latent infection with herpes simplex 
virus type 1 (HSV-1) (Thackray and Bujdoso, 2002). Mice overexpressing transgenic PrPC 
were sensitive to acute infection of HSV-1 strain SC16 in the central and peripheral neuronal 
tissues, exhibiting higher mortality than control mice (Thackray and Bujdoso, 2002). 
However, latent infection of the virus in these tissues was significantly suppressed in these 
mice (Thackray and Bujdoso, 2002). Lower induction of autophagy was reported in Prnp0/0 
astrocytes than in WT astrocytes after infection with HSV-1 strain 17, suggesting that PrPC 
might be involved in induction of autophagy in astrocytes after infection with HSV-1 (Korom 
et al., 2013). However, it remains to be determined whether or not the enhanced acute 
infection of HSV-1 and the suppressed latent infection of HSV-1 in PrPC-overexpressing mice 
can be attributable to the higher induction of autophagy in HSV-1-infected astrocytes. It was 
also reported that PrPC inhibited production of human immunodeficiency virus type 1 
(HIV-1) in cultured cells transfected with an infectious HIV-1 molecular clone (Alais et al., 
2012). PrPC disturbed translation of the HIV-1 genomic RNA probably through binding to the 
genomic RNA (Gabus et al., 2001). It has been further reported that PrPC might be involved 
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in protection against infection with coxsackievirus B3 (Nakamura et al., 2003), adenovirus 5 
(Caruso et al., 2009), and poliovirus-1 (Baj et al., 2005).  
 
Perspectives 
We showed that PrPC has a protective role against lethal infection with IAVs in mice by 
exerting ant-oxidative activity (Chida et al., 2018). Worldwide spread of IAVs, which are 
resistant to the currently available anti-influenza agents, has raised great health concerns 
about pandemics with these resistant IAVs among human populations (Hurt et al., 2009; 
McKimm-Breschkin et al., 1998; Mishin et al., 2005). The currently available agents such as 
neuraminidase inhibitors target the molecules encoded by IAVs, promoting the emergence of 
the IAVs carrying mutations in the genes encoding the targeted molecules and eventually 
propagating these resistant mutant IAVs among human populations (Hurt et al., 2009; 
McKimm-Breschkin et al., 1998; Mishin et al., 2005). Therefore, host molecules involved in 
protection against IAV infection would be plausible targets for development of anti-influenza 
agents because the agents targeting host molecules are considered not to induce resistant 
IAVs. Anti-oxidative therapeutics against IAV infection, by targeting the ROS-generating 
enzymes or by administrating anti-oxidants or anti-oxidant enzymes, has been shown to 
successfully protect mice from lethal infection with IAVs (Akaike et al., 1990; Oda et al., 
1989; Tantcheva et al., 2003; Vlahos and Selemidis, 2014). Our current findings suggest that 
PrPC is a new target molecule for anti-oxidative therapeutics against IAV infection. It has 
been reported that PrPC protected neurons from anisomycin-induced apoptosis via interaction 
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with stress-inducible protein 1 (STI1), a STI1-derived peptide, or anti-PrP antibodies 
(Chiarini et al., 2002; Zanata et al., 2002), and that the interaction with STI1 could be 
involved in PrPC-dependent activation of SOD (Sakudo et al., 2005). It is thus interesting to 
investigate whether these ligands could elicit the anti-oxidative activity of PrPC and protect 
against IAV infection and other virus infections, in which oxidative stress plays a pivotal role 
in the pathogenesis. 
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 1 
Figure legends 1 
FIG. 1. A possible mechanism for the protective role of PrPC against IAV infection-induced 2 
apoptosis. IAV infection in lung epithelial cells causes overproduction of ROS by directly or 3 
indirectly inducing production of inflammatory cytokines, leading to apoptosis in infected 4 
epithelial cells. PrPC could regulate the enzymatic activity of SOD1 by transferring Cu ions, 5 
which are bound to the N-terminal OR region, thereby mitigating the burden of ROS in 6 
infected cells and eventually protecting the cells from undergoing apoptosis.  7 

